EOLSEvolus, Inc.
6.245USD+2.55%Mkt Cap: 409.62M USDP/E: Last update: 2026-05-26

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin…

Indicators:|

Key Statistics

Company
Market Cap409.62M USD
Enterprise Value539.87M USD
Revenue (TTM)301.79M USD
Gross Profit197.11M USD
Net Income (TTM)-51.64M USD
Revenue/Share4.654 USD
Last Price6.245 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees350
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS30052C1071
Valuation
P/E (Trailing)
P/E (Forward)24.19
PEG
EV/EBITDA-23.32
EV/Revenue1.79
P/S1.41
P/B-14.76
EPS (TTM)-0.66
EPS (Forward)0.27
52W Range
3.86035% of range10.62
52W High10.62 USD
52W Low3.860 USD
Profitability
Gross Margin66.33%
Oper. Margin-9.38%
EBITDA Margin-7.67%
Profit Margin-17.38%
ROE223.50%
ROA-22.86%
Growth
Revenue Growth6.70%
Earnings Growth
Cash Flow & Leverage
Operating CF-42.27M USD
CapEx (TTM)8.45M USD
FCF Margin-7.70%
FCF Yield-5.67%
Net Debt115.11M USD
Net Debt/EBITDA-4.97
Balance Sheet
Debt/Equity-6.71
Current Ratio2.04
Quick Ratio1.50
Book Value/Sh-0.4370 USD
Cash/Share0.7560 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)14.67 USD
Target Range10.00 USD20.00 USD
# Analysts6
Ownership
Shares Out.65.85M
Float50.04M
Insiders14.68%
Institutions70.09%
Short Interest
Short Ratio9.0d
Short % Float10.24%
Short % Out.10.11%
Shares Short6.66M
Short (prev mo.)6.52M
Technical
SMA 505.152 (+21.2%)
SMA 2005.946 (+5.0%)
Beta1.29
S&P 52W Chg28.31%
Avg Vol (30d)886.96K
Avg Vol (10d)690.43K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)